Compare Equinor ASA (EQNR) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Equinor ASA trades at $43.02 (market cap $101.62B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Equinor ASA is far larger — about 4× Royalty Pharma plc Class A Ordinary Shares's market cap, and Equinor ASA pays the higher dividend (3.63%). Which is the better fit depends on your goals — on Pluang, investors hold Equinor ASA for 59 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| EQNR | RPRX | |
|---|---|---|
Market Cap | $101.62B | $25.27B |
Volume | 4,991,782 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $45.75 | $63.96 |
52-Week Low | $22.41 | $35.44 |
Typical Hold Time | 59 Days | 1 Days |
Enterprise Value | $110.31B | $32.50B |
Dividend Yield | 3.63% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Equinor (EQNR) trades at $43.01, up 3.36% today, with strong technical momentum indicated by bullish moving averages. The stock shows attractive valuation metrics with a P/E of 11.63 and EV/EBITDA of 2.39, while recent earnings beat expectations in two of the last three quarters. The company maintains solid profitability with 21.32% ROE and continues strategic expansion in LNG markets through new supply agreements.
EQNR presents compelling value with significant upside to the $87.50 consensus price target, though investors face risks from volatile energy prices and declining profit margins. The company's LNG expansion strategy and share buyback program provide catalysts, but execution risks and commodity price sensitivity require careful monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
